<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DrugDDI.d235" origId="Alteplase"><sentence id="DrugDDI.d235.s0" origId="s0" text="The interaction of Activase with other cardioactive or cerebroactive drugs has not been studied."><entity charOffset="19-27" id="DrugDDI.d235.s0.e0" origId="s0.p1" text="Activase" type="drug"/><entity charOffset="69-74" id="DrugDDI.d235.s0.e1" origId="s0.p4" text="drugs" type="drug"/><pair e1="DrugDDI.d235.s0.e0" e2="DrugDDI.d235.s0.e1" id="DrugDDI.d235.s0.p0" interaction="false"/><negationtags>&lt;xcope&gt;The interaction of Activase with other cardioactive or cerebroactive drugs has &lt;cue&gt;not&lt;/cue&gt; been studied&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d235.s1" origId="s1" text="In addition to bleeding associated with heparin and vitamin K antagonists, drugs that alter platelet function (such as acetylsalicylic acid, dipyridamole and Abciximab) may increase the risk of bleeding if administered prior to, during, or after Activase therapy."><entity charOffset="40-47" id="DrugDDI.d235.s1.e0" origId="s1.p12" text="heparin" type="drug"/><entity charOffset="75-80" id="DrugDDI.d235.s1.e1" origId="s1.p15" text="drugs" type="drug"/><entity charOffset="119-139" id="DrugDDI.d235.s1.e2" origId="s1.p20" text="acetylsalicylic acid" type="drug"/><entity charOffset="141-153" id="DrugDDI.d235.s1.e3" origId="s1.p21" text="dipyridamole" type="drug"/><entity charOffset="158-167" id="DrugDDI.d235.s1.e4" origId="s1.p23" text="Abciximab" type="drug"/><entity charOffset="246-254" id="DrugDDI.d235.s1.e5" origId="s1.p34" text="Activase" type="drug"/><pair e1="DrugDDI.d235.s1.e0" e2="DrugDDI.d235.s1.e1" id="DrugDDI.d235.s1.p0" interaction="false"/><pair e1="DrugDDI.d235.s1.e0" e2="DrugDDI.d235.s1.e2" id="DrugDDI.d235.s1.p1" interaction="false"/><pair e1="DrugDDI.d235.s1.e0" e2="DrugDDI.d235.s1.e3" id="DrugDDI.d235.s1.p2" interaction="false"/><pair e1="DrugDDI.d235.s1.e0" e2="DrugDDI.d235.s1.e4" id="DrugDDI.d235.s1.p3" interaction="false"/><pair e1="DrugDDI.d235.s1.e0" e2="DrugDDI.d235.s1.e5" id="DrugDDI.d235.s1.p4" interaction="false"/><pair e1="DrugDDI.d235.s1.e1" e2="DrugDDI.d235.s1.e2" id="DrugDDI.d235.s1.p5" interaction="false"/><pair e1="DrugDDI.d235.s1.e1" e2="DrugDDI.d235.s1.e3" id="DrugDDI.d235.s1.p6" interaction="false"/><pair e1="DrugDDI.d235.s1.e1" e2="DrugDDI.d235.s1.e4" id="DrugDDI.d235.s1.p7" interaction="false"/><pair e1="DrugDDI.d235.s1.e1" e2="DrugDDI.d235.s1.e5" id="DrugDDI.d235.s1.p8" interaction="false"/><pair e1="DrugDDI.d235.s1.e2" e2="DrugDDI.d235.s1.e3" id="DrugDDI.d235.s1.p9" interaction="false"/><pair e1="DrugDDI.d235.s1.e2" e2="DrugDDI.d235.s1.e4" id="DrugDDI.d235.s1.p10" interaction="false"/><pair e1="DrugDDI.d235.s1.e2" e2="DrugDDI.d235.s1.e5" id="DrugDDI.d235.s1.p11" interaction="true"/><pair e1="DrugDDI.d235.s1.e3" e2="DrugDDI.d235.s1.e4" id="DrugDDI.d235.s1.p12" interaction="false"/><pair e1="DrugDDI.d235.s1.e3" e2="DrugDDI.d235.s1.e5" id="DrugDDI.d235.s1.p13" interaction="true"/><pair e1="DrugDDI.d235.s1.e4" e2="DrugDDI.d235.s1.e5" id="DrugDDI.d235.s1.p14" interaction="true"/></sentence><sentence id="DrugDDI.d235.s2" origId="s2" text="Use of Antithrombotics Aspirin and heparin have been administered concomitantly with and following infusions of Activase in the management of acute myocardial infarction or pulmonary embolism."><entity charOffset="23-30" id="DrugDDI.d235.s2.e0" origId="s2.p36" text="Aspirin" type="drug"/><entity charOffset="35-42" id="DrugDDI.d235.s2.e1" origId="s2.p38" text="heparin" type="drug"/><entity charOffset="112-120" id="DrugDDI.d235.s2.e2" origId="s2.p46" text="Activase" type="drug"/><pair e1="DrugDDI.d235.s2.e0" e2="DrugDDI.d235.s2.e1" id="DrugDDI.d235.s2.p0" interaction="false"/><pair e1="DrugDDI.d235.s2.e0" e2="DrugDDI.d235.s2.e2" id="DrugDDI.d235.s2.p1" interaction="false"/><pair e1="DrugDDI.d235.s2.e1" e2="DrugDDI.d235.s2.e2" id="DrugDDI.d235.s2.p2" interaction="false"/></sentence><sentence id="DrugDDI.d235.s3" origId="s3" text="Because heparin, aspirin, or Activase may cause bleeding complications, careful monitoring for bleeding is advised, especially at arterial puncture sites."><entity charOffset="8-15" id="DrugDDI.d235.s3.e0" origId="s3.p52" text="heparin" type="drug"/><entity charOffset="17-24" id="DrugDDI.d235.s3.e1" origId="s3.p53" text="aspirin" type="drug"/><entity charOffset="29-37" id="DrugDDI.d235.s3.e2" origId="s3.p55" text="Activase" type="drug"/><pair e1="DrugDDI.d235.s3.e0" e2="DrugDDI.d235.s3.e1" id="DrugDDI.d235.s3.p0" interaction="false"/><pair e1="DrugDDI.d235.s3.e0" e2="DrugDDI.d235.s3.e2" id="DrugDDI.d235.s3.p1" interaction="false"/><pair e1="DrugDDI.d235.s3.e1" e2="DrugDDI.d235.s3.e2" id="DrugDDI.d235.s3.p2" interaction="false"/></sentence><sentence id="DrugDDI.d235.s4" origId="s4" text="The concomitant use of heparin or aspirin during the first 24 hours following symptom onset were prohibited in The NINDS t-PA Stroke Trial."><entity charOffset="23-30" id="DrugDDI.d235.s4.e0" origId="s4.p67" text="heparin" type="drug"/><entity charOffset="34-41" id="DrugDDI.d235.s4.e1" origId="s4.p69" text="aspirin" type="drug"/><entity charOffset="97-105" id="DrugDDI.d235.s4.e2" origId="s4.p74" text="prohibit" type="drug"/><pair e1="DrugDDI.d235.s4.e0" e2="DrugDDI.d235.s4.e1" id="DrugDDI.d235.s4.p0" interaction="true"/><pair e1="DrugDDI.d235.s4.e0" e2="DrugDDI.d235.s4.e2" id="DrugDDI.d235.s4.p1" interaction="false"/><pair e1="DrugDDI.d235.s4.e1" e2="DrugDDI.d235.s4.e2" id="DrugDDI.d235.s4.p2" interaction="false"/></sentence><sentence id="DrugDDI.d235.s5" origId="s5" text="The safety of such concomitant use with Activase for the management of acute ischemic stroke is unknown."><entity charOffset="40-48" id="DrugDDI.d235.s5.e0" origId="s5.p78" text="Activase" type="drug"/></sentence></document>